TITLE

MEDICAL PERSPECTIVES OF CORONARY ARTERY DISEASE

AUTHOR(S)
Russek, Henry I.
PUB. DATE
January 1967
SOURCE
Angiology;Jan1967, Vol. 18 Issue 1, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In myocardial infarction, in spite of the major advances in diagnosis and therapy, it must still be recognized that under proper supervision a large proportion of cases will run their course from beginning to end with little or no need for medication. Since hazards exist even with skillful use of therapeutic measures by competent physicians, overtreatment arising from the application of �routine� programs should be discouraged. It is only by adherence to the important principle of treating each patient individually that the dangers of indiscriminate therapy may be avoided. The use of potentially dangerous agents in acute coronary occlusion without clear indication is not justified. It is the physician's responsibility to be as aware of the hazards as of the triumphs of modern therapy and to utilize such knowledge in the choice of specific measures for the individual case. In angina pectoris, the therapeutic role of the physician is by no means secondary to that of drug treatment. Nevertheless, the employment of long-acting nitrates, in particular, isosorbide dinitrate sublingually or pentaerythritol tetranitrate orally, in conjunction with careful counseling, represents a distinct advance in the prophylactic therapy of angina pectoris. The prudent use of these long-acting drugs requires a knowledge not only of dosage, time of onset, and duration of action in relation to route of administration but also of the pattern of anginal episodes and drug tolerance in the individual case. Failure to utilize available benefits may deprive the patient with angina pectoris of considerable comfort, assurance, and productivity.
ACCESSION #
16441713

 

Related Articles

  • Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs. Eddy, David M.; Adler, Joshua; Patterson, Bradley; Lucas, Don; Smith, Kurt A.; Morris, Macdonald // Annals of Internal Medicine;5/3/2011, Vol. 154 Issue 9, p627 

    Background: Current guidelines focus on a particular risk factor and specify criteria for categorizing persons into a small number of treatment groups. Objective: To compare current guidelines with individualized guidelines (that use readily available characteristics from each person to...

  • Glycoprotein IIb/IIIa Receptor Inhibitors in Acute Coronary Syndromes: Conquests and New Challenges. Smith, Karen M.; Mehta, Jawahar L. // Journal of Cardiovascular Pharmacology & Therapeutics;Sep2000, Vol. 5 Issue 3, p143 

    The article presents a review of medical literature on the role of the platelet in the pathophysiology of ischemic cardiovascular diseases and the effects of platelet-inhibitory agents in the treatment of acute coronary syndromes (ACS). It is noted that medical advances in coronary disease...

  • Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin. Dormuth, Colin R.; Maclure, Malcolm; Carney, Greg; Schneeweiss, Sebastian; Bassett, Ken; Wright, James M. // PLoS ONE;2009, Vol. 4 Issue 6, p1 

    Objective: Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial infarction (AMI) in a two meta-analyses of clinical trials. Our objective is to estimate the magnitude of the association in real-world patients previously treated with metformin. Research...

  • Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction. Zongjin Li; Wilson, Kitchener D.; Smith, Bryan; Kraft, Daniel L.; Fangjun Jia; Mei Huang; Xiaoyan Xie; Robbins, Robert C.; Gambhir, Sanjiv S.; Weissman, Irving L.; Wu, Joseph C. // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Background: Differentiation of human embryonic stem cells into endothelial cells (hESC-ECs) has the potential to provide an unlimited source of cells for novel transplantation therapies of ischemic diseases by supporting angiogenesis and vasculogenesis. However, the endothelial differentiation...

  • Medication Adherence After Myocardial Infarction: A Long Way Left To Go. Choudhry, Niteesh K.; Winkelmayer, Wolfgang C. // JGIM: Journal of General Internal Medicine;Feb2008, Vol. 23 Issue 2, p216 

    The author reflects on the developments surrounding the medication for the treatment and prevention of myocardial infarction. The medications of coronary heart disease have been subject to various evaluation in trials. Several drugs, which are taken in combination, have been estimated to reduce...

  • Coronary Artery Disease -- Myocardial Infarction.  // Current Medical Literature: Interventional Cardiology Monitor;2006, Vol. 13 Issue 4, p111 

    The article expresses views on the study "Early Invasive Versus Conservative Strategies for Unstable Angina and Non-ST-Elevation Myocardial Infarction in the Stent Era," by M. R. Hoenig, J. A. Doust et al. It states that the study presents the results of a systematic review performed by the...

  • Drug-Eluting Stents in Percutaneous Coronary Intervention. Byrne, Robert A.; Sarafoff, Nikolaus; Kastrati, Adnan; Schömig, Albert // Drug Safety;2009, Vol. 32 Issue 9, p749 

    Drug-eluting stent (DES) therapy has represented a very significant milestone in the evolution of percutaneous coronary intervention (PCI) therapy. This review attempts to provide a balanced overview of the unprecedented wealth of data generated on this new technology, by examining the evidence...

  • IC Eptifibatide Compared with IC Tirofiban In Patients With Acute Anterior STEMI Undergoing Primary PCI. Vinall, Phil // MD Conference Express;Oct2011, p14 

    The article focuses on the result of a study which compares the intracoronary (IC) eptifibatide and IC tirofiban for the treatment of acute anterior ST segment elevation myocardial infarction (STEMI) in patients undergoing primary percutaneous intracoronary intervention (PCI). The study was...

  • THE PRESYSTOLIC GALLOP IN ACUTE MYOCARDIAL INFARCTION. Gould, Lawrence; Umali, Franlina; Gomprecht, Robert F. // Angiology;Oct1972, Vol. 23 Issue 9, p549 

    The presystolic gallop is usually present in acute myocardial infarction. The eventual fate of this gallop is not well established. Therefore 20 patients admitted to the coronary care unit with chest pain and a subsequently documented myocardial infarction were followed with serial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics